Feb 29 |
Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
|
Feb 20 |
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
|
Feb 7 |
Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
|
Feb 6 |
Evaxion Announces Closing of $15 Million Public Offering
|
Feb 1 |
Evaxion Biotech to raise ~$15M through public offering of shares and warrants
|
Feb 1 |
Evaxion Biotech Announces Pricing of $15 Million Public Offering
|
Jan 31 |
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Jan 24 |
Evaxion stock rallies 120% on AI-based cancer vaccine program
|
Jan 24 |
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
|
Jan 22 |
Evaxion Announces Completion of ADS Ratio Change
|